Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3990 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Lupin gets FDA nod for generic antibiotic

According to a source quoted by the company, Omnicef Capsules had US sales of approximately $232 million last year. Cefdinir is an extended-spectrum semisynthetic cephalosporin used to treat

BMS/Otsuka schizophrenia drug beats rivals in study

The data are from a study called STAR, which was performed in community-based treatment settings, evaluating more than 500 adults with schizophrenia. In the study, aripiprazole demonstrated significantly

Genentech up on new Avastin filing

The supplemental biologics license application (sBLA) submission is for the use of Avastin (bevacizumab) in combination with taxane chemotherapy in patients who have not previously received chemotherapy for

Antipodean begins phase II Parkinson’s trial

MitoQ (mitoquinone) is a compound based on a novel technology, targeted lipophilic cations, that transport and concentrate antioxidants into the mitochondria where they accumulate up to 1,000-fold. There

Allergan receives pan-European license for Ganfort

Ganfort (bimatoprost/timolol ophthalmic solution) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers